Quarterly report pursuant to Section 13 or 15(d)

BUSINESS (Details Narrative)

v3.8.0.1
BUSINESS (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2018
Dec. 31, 2017
Jul. 28, 2016
State of Incorporation Nevada    
BioCorRx Pharmaceuticals, Inc [Member]      
Licensing rights, carrying value $ 250,000 $ 250,000  
BioCorRx Pharmaceuticals, Inc [Member] | BioCorRx, Inc [Member]      
Equity issued ownership     75.80%
Officer [Member] | BioCorRx Pharmaceuticals, Inc [Member]      
Equity issued ownership     24.20%